Class II · Moderate risk
Xylocaine - MPF
cGMP deviations: Temperature abuse
Is Epinephrine recalled?
Yes — there is an active recall. 19 ongoing FDA recalls mention Epinephrine (118 total). Check the affected lots below.
Recalls are matched by product description. A recall usually affects specific lots, not every package of Epinephrine. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.
Epinephrine recalls on record
none so far in 2026; 118 on record, newest first
Class II · Moderate risk
Spinal Tray
cGMP deviations: Temperature abuse
Class II · Moderate risk
Adrenalin (epinephrine injection, USP)
cGMP deviations: Temperature abuse
Class II · Moderate risk
Epinephrine Injection
cGMP deviations: Temperature abuse
Class II · Moderate risk
Epinephrine Injection
cGMP deviations: Temperature abuse
Class II · Moderate risk
EPI-Pen Jr
cGMP deviations: Temperature abuse
Class II · Moderate risk
Epi-Pen 2-Pak
cGMP deviations: Temperature abuse
Class I · High risk
SYMJEPI (epinephrine injection, USP)
Defective Delivery System: Potential clogging of the needle preventing the dispensing of epinephrine.
Class I · High risk
SYMJEPI (epinephrine injection, USP)
Defective Delivery System: Potential clogging of the needle preventing the dispensing of epinephrine.
Class II · Moderate risk
Epinephrine Injection 8 mg per 250 mL in 0.9% Sodium Chloride
Defective container
Class II · Moderate risk
Epinephrine/Lidocaine HCl Sterile Ophthalmic Solution for Injection
Lack of Assurance of Sterility
Class II · Moderate risk
Lidocaine HCl/Epinephrine
Lack of Assurance of Sterility
Class II · Moderate risk
EPINEPHrine in 0.9% Sodium Chloride Injection
Lack of Assurance of Sterility
Class II · Moderate risk
EPINEPHrine
Lack of Assurance of Sterility
Class II · Moderate risk
Xylocaine-MPF with Epinephrine 1:200
Low out of specification results for epinephrine assay.
Class II · Moderate risk
Epinephrine Injection USP
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Class II · Moderate risk
Epinephrine Injection USP
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Class II · Moderate risk
Epinephrine Injection
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Class III · Low risk
Epinephrine/Lidocaine HCl
Labeling: Incorrect or Missing Lot and/or Exp Date
Class II · Moderate risk
Sensorcaine-MPF
Subpotent Drug: Low out-of-specification assay results for the epinephrine component.
Class III · Low risk
R.E.C.K. (Ropivacaine, Epinephrine, Clonidine, Ketorolac)
Presence of Particulate Matter: Fresenius Kabi recalling vials of Ketorolac
Class II · Moderate risk
Epinephrine Injection USP
CGMP Deviations: Precautions taken due to Out-of-specification for trigger force for a non-marketed lot number that shares the same component.
Class II · Moderate risk
LIDOCAINE 0.75%/Epinephrine 0.025%/BSS 0.56ML SYR
Lack of Assurance of Sterility
Class II · Moderate risk
EPINEPHrine 1:1000 INJECTION SOLUTION
Lack of Assurance of Sterility
Class II · Moderate risk
EPINEPHrine 4MG ADDED TO D5W 5%
Lack of Assurance of Sterility
Free recall alerts
Know the day your medication is recalled
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.